The need for easily biodegradable and less toxic chemicals in drug development and pest control continues to fuel the exploration and discovery of new natural molecules. Like certain plants, some insects can also respond rapidly to microbial infections by producing a plethora of immune-induced molecules that include antibacterial and antifungal peptides/polypeptides (AMPs), among other structurally diverse small molecules. The recent recognition that new natural product-derived scaffolds are urgently needed to tackle life-threatening pathogenic infections has been prompted by the health threats posed by multidrug resistance. Although many researchers have concentrated on the discovery of AMPs, surprisingly, edible insect-produced AMPs/small molecules have received little attention. This review will discuss the recent advances in the identification and bioactivity analysis of insect AMPs, with a focus on small molecules associated with the microbiota of selected African edible insects. These molecules could be used as templates for developing next-generation drugs to combat multidrug-resistant pathogens.

Natural products hold immense potential for drug discovery, yet many remain unexplored in vast libraries and databases. In an attempt to fill this gap and meet the growing demand for effective drugs, this study delves into the promising world of ent-kaurane diterpenoids, a class of natural products with huge therapeutic potential. With a dataset of 570 ent-kaurane diterpenoids obtained from the literature, we conducted an in silico analysis, evaluating their physicochemical, pharmacokinetic, and toxicological properties with a focus on their therapeutic implications. Notably, these natural compounds exhibit drug-like properties, aligning closely with those of FDA-approved drugs, indicating a high potential for drug development. The ranges of the physicochemical parameters were as follows: molecular weights—288.47 to 626.82 g/mol; number of heavy atoms—21 to 44; the number of hydrogen bond donors and acceptors—0 to 8 and 1 to 11, respectively; the number of rotatable bonds—0 to 11; fraction Csp3—0.65 to 1; and TPSA—20.23 to 189.53 Ų. Additionally, the majority of these molecules display favorable safety profiles, with only 0.70%, 1.40%, 0.70%, and 46.49% exhibiting mutagenic, tumorigenic, reproduction-enhancing, and irritant properties, respectively. Importantly, ent-kaurane diterpenoids exhibit promising biopharmaceutical properties. Their average lipophilicity is optimal for drug absorption, while over 99% are water-soluble, facilitating delivery. Further, 96.5% and 28.20% of these molecules exhibited intestinal and brain bioavailability, expanding their therapeutic reach. The predicted pharmacological activities of these compounds encompass a diverse range, including anticancer, immunosuppressant, chemoprotective, anti-hepatic, hepatoprotectant, anti-inflammation, antihyperthyroidism, and anti-hepatitis activities. This multi-targeted profile highlights ent-kaurane diterpenoids as highly promising candidates for further drug discovery endeavors.

Edible insects are increasingly gaining popularity as research reveals multiple benefits. However, the rediscovery of natural products from insects as medicinal agents has received limited attention. This study aimed at evaluating the diversity of sterols in extracts of nine edible insects and potential antibacterial activities. Dichloromethane extracts of these insects were analyzed using gas chromatography–mass spectrometry to identify important sterols, followed by evaluation of their anti-bacterial activities. Nineteen sterols were identified with the highest recorded in African fruit beetle [Pachnoda sinuata (47.37%)], crickets [Gryllus bimaculatus (36.84%) and Scapsipedus icipe (31.58%)]. Cholesterol was the most prevalent, except in black soldier fly (Hermetia illucens). Bioactivity revealed S. icipe as the most potent extract against Escherichia coli and Bacillus subtilis whereas G. bimaculatus was highest against Methicillin-susceptible Staphylococcus aureus 25923. These findings unravels the diversity of sterols in edible insects and their possible application in food, pharmaceutical and cosmetic industries.

Background: Gut microbiota have several advantages in influencing the host nutrition, metabolism, immunity and growth. However, the understanding of the gut microbiota in key edible wood-boring beetle larvae remain largely undefined. In the present study, the characteristics of the gut microbiota of two edible wood-boring species (Titocerus jaspideus and Passalus punctiger) from two indigenous forested areas were investigated. Results: Over 50% of Amplicon Sequence Variants (ASVs) constituted of Firmicutes in T. jaspideus. The dominant phyla in both beetle species were Bacteroidota (4.20–19.79%) and Proteobacteria (15.10–23.90%). Lactococcus lactis was the most abundant and core prokaryote in the guts of T. jaspideus. The fungi identified in the gut of both insects belong to the phylum Obazoa (66%) and Ascomycota (> 15%). Scheffersomyeces sp. was the core eukaryote recorded. The diversity of gut microbiota in both insect species did not vary significantly. Most of the prokaryotic genes expressed were predominantly associated with biosynthesis and metabolism. Conclusion: Our findings demonstrated that Lactococcus lactis and Scheffersomyeces are core gut microbes of wood boring beetle larvae with desirable probiotic properties and promising use in food product fermentation for improved growth performance, gut barrier health, intestinal flora balance and immune protection for human and animals. Further studies to highlight the latest medical-based applications of L. lactis as live-delivery vector for the administration of therapeutics against both communicable and non-communicable diseases are warranted.

Edible scarab beetles are important repositories for nutritive and bioactive compounds, but this information remains largely unexplored. This study explored the nutritional and therapeutic properties of two edible scarab beetles from three different locations (Embu, Murang’a and Nairobi Counties) in Kenya. Morphological and molecular characterization of the wild collected larvae revealed two important edible beetle species ( Cetonia aurata L. and Oryctes rhinoceros L.). The larvae of both species are excellent source of crude proteins (44% for O. rhinoceros and 63% for C. aurata ). The larvae of O. rhinoceros were rich in minerals, particularly calcium (15.75-22.65 mg/g) and potassium (13.62-22.88 mg/g). The anti-radical activity of C. aurata larvae ranged between 91% and 92% across the various target sites. Lysine was the most important and abundant amino acid in both larvae (>5 mg/g). The larvae of C. aurata and O. rhinoceros are a good source of unsaturated fatty acids like Methyl-8 Z , 11 Z , 14Z-eicosatrienoate (32 mg/g) and Methyl-9 Z -octadecenoate (9.47-120.84 mg/g). The entomochemicals of phenolic nature derived from the beetle larvae portray a unique opportunity to supply and improve high quality nutritious food with enhanced ability to get-rid of free radicals, thus promoting good health and well-being of the consumers. Future development of foods supplemented with scarab beetle larvae derived products must consider the preservation of potential benefits of not only nutrients, but also nutraceuticals. However, in-depth research is still needed to guarantee the bioactivity in processed foods and ensure quality control test before the release of these products to the market.